PXSGX
Price
$17.97
Change
+$0.21 (+1.18%)
Updated
Aug 21 closing price
Net Assets
595.9M
VEXRX
Price
$126.53
Change
+$0.81 (+0.64%)
Updated
Aug 21 closing price
Net Assets
22.12B
Interact to see
Advertisement

PXSGX vs VEXRX

PXSGX vs VEXRX Comparison Chart in %
View a ticker or compare two or three
VS
PXSGX vs. VEXRX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PXSGX is a Hold and VEXRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 22.1B vs. PXSGX (596M). VEXRX pays higher dividends than PXSGX: VEXRX (0.49) vs PXSGX (0.00). PXSGX was incepted earlier than VEXRX: PXSGX (20 years) vs VEXRX (25 years). PXSGX (1.12) is less costly to investors than VEXRX (0.28). VEXRX is a more actively managed with annual turnover of: 51.00 vs. PXSGX (18.00). VEXRX has a lower initial minimum investment than PXSGX: VEXRX (50000) vs PXSGX (100000). VEXRX annual gain was more profitable for investors over the last year : 17.56 vs. PXSGX (-38.54). VEXRX return over 5 years is better than : -5.23 vs. PXSGX (-67.03).
PXSGXVEXRXPXSGX / VEXRX
Total Expense Ratio1.120.28400%
Annual Report Gross Expense Ratio1.120.28400%
Fund Existence20 years25 years-
Gain YTD3.87318.59621%
Front LoadN/AN/A-
Min. Initial Investment10000050000200%
Min. Initial Investment IRAN/AN/A-
Net Assets596M22.1B3%
Annual Yield % from dividends0.000.49-
Returns for 1 year-38.5417.56-219%
Returns for 3 years-45.7634.85-131%
Returns for 5 years-67.03-5.231,282%
Returns for 10 years-6.0155.04-11%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THPMX17.600.14
+0.80%
Thompson MidCap
AIVBX22.210.17
+0.77%
American Funds Intl Vntg A
GSSUX45.930.22
+0.48%
Goldman Sachs Small Cap Value R6
TSNIX70.000.19
+0.27%
T. Rowe Price Science & Tech I
JMNAX14.04-0.01
-0.07%
JPMorgan Research Market Neutral A